ArticleScientific reports2021

Pharmacologic targeting of Cdc42 GTPase by a small molecule Cdc42 activity-specific inhibitor prevents platelet activation and thrombosis.

Xin Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.